LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs

被引：430
|
作者：
Lesage, S [1 ]
Dürr, A
Tazir, M
Lohmann, E
Leutenegger, AL
Janin, S
Pollak, P
Brice, A
机构：
[1] INSERM, U679, F-75651 Paris 13, France
[2] CHU Mustapha, Algiers 16000, Algeria
[3] CHU Grenoble, F-38000 Grenoble, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 04期
关键词：
D O I：
10.1056/NEJMc055540
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：422 / 423
页数：2
相关论文
共 50 条
  • [41] G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
    Gaig, Carles
    Marti, Maria Jose
    Ezquerra, Mario
    Rey, Maria Jesus
    Cardozo, Adriana
    Tolosa, Eduardo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (06): : 626 - 628
  • [42] Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease
    Squillaro, Tiziana
    Cambi, Franca
    Ciacci, Giuseppe
    Rossi, Simone
    Ulivelli, Monica
    Malandrini, Alessandro
    Mencarelli, Maria Antonietta
    Mari, Francesca
    Renieri, Alessandra
    Ariani, Francesca
    JOURNAL OF HUMAN GENETICS, 2007, 52 (03) : 201 - 204
  • [43] LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease
    Bouhouche, Ahmed
    Tibar, Houyam
    Ben El Haj, Rafiqua
    El Bayad, Khalil
    Razine, Rachid
    Tazrout, Sanaa
    Skalli, Asmae
    Bouslam, Naima
    Elouardi, Loubna
    Benomar, Ali
    Yahyaoui, Mohammed
    Regragui, Wafa
    PARKINSONS DISEASE, 2017, 2017
  • [44] Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease
    Kay, Denise M.
    Bird, Tom D.
    Zabetian, Cyrus P.
    Factor, Stewart A.
    Samii, Ali
    Higgins, Donald S.
    Nutt, John
    Roberts, John W.
    Griffith, Alida
    Leis, Berta C.
    Montimurro, Jennifer S.
    Philpott, Sean
    Payami, Haydeh
    GENETIC TESTING, 2006, 10 (03): : 221 - 227
  • [45] Leukocyte MAPK activity associated with the LRRK2 G2019S mutation and Parkinson's disease
    Aasly, J. O.
    Toft, M.
    Farrer, M. J.
    Kvam, S. N.
    White, L. R.
    MOVEMENT DISORDERS, 2006, 21 : S416 - S416
  • [46] Different origins and demographic histories of the LRRK2 G2019S mutation in Parkinson's disease
    Lesage, S.
    Patin, E.
    Condroyer, C.
    Lentenegger, A-L
    Lohmann, E.
    Pollak, P.
    Ouvrard-Hernandez, A-M
    Bardien-Kruger, S.
    Tomiyama, H.
    Basak, N.
    Durr, A.
    Hattori, N.
    Orr-Urtreger, A.
    Tazir, M.
    Quintana-Murci, L.
    Brice, A.
    MOVEMENT DISORDERS, 2009, 24 : S143 - S143
  • [47] LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic
    Ben Romdhan, Sawssan
    Farhat, Nouha
    Nasri, Amina
    Lesage, Suzanne
    Hdiji, Olfa
    Ben Djebara, Mouna
    Landoulsi, Zied
    Stevanin, Giovanni
    Brice, Alexis
    Damak, Mariem
    Gouider, Riadh
    Mhiri, Chokri
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (05): : 425 - 431
  • [48] Frequency of the LRRK2 G2019S mutation in patients with Parkinson's disease in Russian population
    Bagyeva, G. K.
    Illarioshkin, S. N.
    Slominsky, P. A.
    Klyushnikov, S.
    Zagorovskaya, T. B.
    Shadrina, M. I.
    Polevaya, E. V.
    Nurmanova, S. A.
    Markova, E. D.
    Limborska, S. A.
    Ivanova-Smolenskaya, I. A.
    MOVEMENT DISORDERS, 2006, 21 : S407 - S407
  • [49] Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
    Guedes, L. Correia
    Ferreira, J. J.
    Rosa, M. M.
    Coelho, M.
    Bonifati, V.
    Sampaio, C.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (04) : 237 - 242
  • [50] Investigation of LRRK2 G2019S Mutation in the Patients with Sporadic Parkinson's Disease in Turkey
    Aslan, Huseyin
    Ozkan, Serhat
    Tepeli, Emre
    Emre, Ramazan
    Kutlay, Ozden
    Gurler, Abdullah Ihsan
    Uludag, Ahmet
    Muslumanoglu, M. Hamza
    KONURALP TIP DERGISI, 2014, 6 (01): : 1 - 4
12345